| 000 | 01700 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515224200.0 | ||
| 264 | 0 | _c20100617 | |
| 008 | 201006s 0 0 hun d | ||
| 022 | _a0030-6002 | ||
| 024 | 7 |
_a10.1556/OH.2010.28900 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFehér, János | |
| 245 | 0 | 0 |
_a[Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. _h[electronic resource] |
| 260 |
_bOrvosi hetilap _cJun 2010 |
||
| 300 |
_a933-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzenesulfonates _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xblood |
| 650 | 0 | 4 |
_aCopper _xmetabolism |
| 650 | 0 | 4 |
_aDeveloped Countries _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDeveloping Countries _xstatistics & numerical data |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xcomplications |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aIron _xmetabolism |
| 650 | 0 | 4 |
_aLiver Cirrhosis, Alcoholic _xcomplications |
| 650 | 0 | 4 |
_aLiver Cirrhosis, Biliary _xcomplications |
| 650 | 0 | 4 |
_aLiver Neoplasms _xblood |
| 650 | 0 | 4 |
_aMetabolic Diseases _xcomplications |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 650 | 0 | 4 | _aSorafenib |
| 700 | 1 | _aLengyel, Gabriella | |
| 773 | 0 |
_tOrvosi hetilap _gvol. 151 _gno. 23 _gp. 933-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1556/OH.2010.28900 _zAvailable from publisher's website |
| 999 |
_c19847920 _d19847920 |
||